Aureus Asset Management, LLC Gilead Sciences, Inc. Transaction History

Aureus Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $164,378 - $206,677	-2,647 Closed	0 $0
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $191,483 - $222,348	2,647 New	2,647 $204,000
Q1 2020 May 14, 2020	SELL	$62.63 - $80.22 $222,837 - $285,422	-3,558 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$61.62 - $67.78 $219,243 - $241,161	3,558 New	3,558 $231,000
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $351,962 - $429,081	-4,832 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$72.11 - $85.47 $348,435 - $412,991	4,832	4,832 $391,000

1,893

1.02B

12M

9.04M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Aureus Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Aureus Asset Management, LLC with notifications on news.